CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Tropifexor plus cenicriviroc combination versus monotherapy in non-alcoholic steatohepatitis: Results from the Phase 2b TANDEM study
Authors
Abdelmalek MF
Anstee QM
+24 more
Brass C
Charlton M
Chen L
Chng E
Francque S
Gadano AC
Goh G
Kochuparampil J
Lazas D
Loomba R
Lucas KJ
Martic M
Mena E
Naoumov NV
Noureddin M
Pedrosa MC
Ratziu V
Rinella M
Rodriguez-Araujo G
Sanyal AJ
Sarin SK
Schattenberg JM
Stringer R
Yilmaz Y
Publication date
Publisher
Lippincott, Williams & Wilkins
Abstract
Abstract is not available.
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Newcastle University E-Prints
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:eprints.ncl.ac.uk:295557
Last time updated on 08/01/2024